Headlines Covid-19 Specialties Trending Feeds Videos

Correspondence from The New England Journal of Medicine — Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351

  • This @NEJM paper suggesting 30% efficacy of the vaccine against B117 in Qatar is making the rounds. Really nice design for post 2nd dose vaccination, but the do not include a time-lag for 14 days post first dose (at least I can see in the paper/supp) 1/3 https://t.co/ROb5LeyotM - view on twitter